logo


CompuMed’s Osteogram Technology Featured at RSNA
Monday, December 01, 2008 8:26 AM


Software-Based Osteoporosis Detection System on Display with Leading OEM Partners Including Fuji, SwissRay and CareStream Health

CompuMed, Inc. (OTCBB:CMPD) (www.compumed.net) -- a medical informatics company serving the healthcare community with diagnostic software solutions – is teaming up with key OEM partners to showcase its OsteoGram® bone density imaging system this week at the 94th Annual Meeting of the Radiological Society of North America (RSNA) in Chicago.

The OsteoGram is on display with OEMs that have integrated the system with their own industry leading applications. OsteoGram OEMs at RSNA include CareStream Health (North Building – Hall B, Booth 8342), FujiFilm Medical Systems (South Building – Hall A, Booth 4039) and Swissray International (East Building – Hall D, Booth 1809).

The software-based OsteoGram system employs a patented imaging process to measure bone density from a standard hand x-ray. It is compatible with DICOM standards and has been shown in numerous clinical studies to provide effective and accurate bone density measurement for screening osteoporosis and assessing hip fracture risk. It has also demonstrated significant cost advantages over other available screening technologies.

“We are delighted to team up with some of the most renowned names in medical imaging to showcase the OsteoGram at RSNA,” said CompuMed CEO Maurizio Vecchione.

The 2008 RSNA meeting is currently under way (November 30th – December 4th) at Chicago’s McCormick Place. It is the world’s largest medical conference and expo. This year’s meeting is expected to be attended by more than 60,000 medical and scientific professionals from around the globe.

More information about the OsteoGram is available from CompuMed’s authorized OEM and distribution partners or by visiting www.CompuMed.net.

About CompuMed

CompuMed, Inc. (OTCBB:CMPD) develops and markets products and services that combine advanced imaging with medical informatics. Its focus is on analysis and remote monitoring for patients with cardiovascular and musculoskeletal diseases. The Company has specialized expertise and intellectual property in telemonitoring imaging and analysis designed to improve healthcare provider workflow and patient care while reducing costs. CompuMed's core products, the OsteoGram(R) and CardioGram(TM), are cleared by the FDA and reimbursable by Medicare.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia